NASDAQ·Pharmaceutical Preparations

XERSXeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc. (XERS) has a auditor change flag.

Last filing: filing·May 7, 2026EDGAR ↗

XERS Risk Flags

Consolidated view of every risk_flag row XERShas surfaced across DredgeCap's extractor pipeline (auditor changes, late filings, delistings, going-concern, dilution, etc.). Each row carries a verbatim source_excerpt and links to the source SEC filing on EDGAR.

Category	Severity	Source	Excerpt	EDGAR
Auditor Change	low	10-K · Mar 2, 2026	PCAOB-tagged auditor in 10-K filed 2026-03-02 (accession 0001867096-26-000016) was 'Ernst & Young LLP' (PCAOB Firm ID: 42). Prior 10-K filed 2025-03-06 (accession 0001867096-25-000039) was 'KPMG LLP' (PCAOB Firm ID: 185).	view ↗

Related on XERS

Auditor & opinion →

Source for auditor_change + going-concern flags.

Share-count dilution →

Source for dilution + convertible-debt flags.

Risk-flag rows are produced by DredgeCap's extractor pipeline (lib/extract-auditor-changes, extract-late-filings, etc.). Each row carries a verbatim source_excerpt from the underlying SEC filing — no AI-generated language. Refresh runs daily. Not financial advice.